期刊文献+

男性雄激素性秃发患者的临床特征及治疗前后皮肤镜征象分析 被引量:9

A retrospective analysis of clinical,dermoscopic features of male patients with androgenic alopecia before and after treatment
下载PDF
导出
摘要 目的:分析576例男性雄激素性秃发(AGA)患者的临床、皮肤镜特征及疗效。方法:对AGA患者进行问卷调查建立专科病历,对其中的391例进行皮损部位的皮肤镜观察并和118例正常人作对照,采用7级评分法进行疗效评价。结果:该研究中77.6%的患者发病年龄在21。40岁,89.1%病程在半年以上,61.3%有阳性家族史;95.3%的患者脱发表现为男性型,且82.4%的患者病情在Hamilton分级Ⅱ~Ⅳ级之间。皮肤镜下特征性的征象有〉20%的毛发直径变细、毛周征、毳毛增多、局部无毛征等,其中〉20%的毛发直径变细的发生率最高为87.5%,而对照组仅为3.4%。联合口服非那雄胺和外用米诺地尔治疗的有效率为75.2%,治疗3个月以上的有效率明显高于不足3个月者,疗程3个月以上的有效率达76.9%-86.7%,疗效与疗程成正相关关系。结论:AGA患者以轻中度脱发的青中年男性为主。皮肤镜在早期诊断AGA及评价疗效中有重要价值,〉20%的毛发直径变细为早期诊断的重要标准。联合口服非那雄胺和外用米诺地尔治疗AGA疗效确切,但至少需坚持3个月。 Objective: To analyze clinical, dermoscopic features and therapeutic efficacy of 576 male patients with androgenic alopecia (AGA). Methods: Clinical data were collected with a questionnaire from 576 male AGA patients. Lesions in 391 AGA were examined with dermoscopy and 118 normal volunteers served as controls. The 7-level scoring method was employed to evaluate the therapeutic efficacy. Results: 77.6% male patients had AGA at ages of 21-40 years; 89.1% patients had AGA for more than six months; 61.3% had a family history of AGA. Among AGA patients, 95.3% patients were male pattern hair loss, and 82.4% were at Hamilton grade II-IV. Dermoscopic features included more than 20% hair diameter diversity (HDD), peripilar signs, increased thinner hair shaft and focal atrichia. 87.5% patients had more than 20% HDD while only 3.4% normal controls had more than 20% HDD. The total effective rate after combination of oral finasteride and topical 5% minoxidil was 75.2%. The effective rates were 76.9%-86.7% following 3-month treatment. The effectiveness was positively correlated with the duration of treatment. Conclusions: Most of AGA patients are young to middle-aged males with mild to moderate hair loss. Demoscopy is a valuable tool for early diagnosis and evaluation of therapeutic efficacy of AGA. The presence of more than 20% HDD is an important criterion for early diagnosis of AGA. Combination of finasteride and minoxidil is effective in treating AGA, but at least 3-month treatment is required.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2013年第12期727-730,共4页 Journal of Clinical Dermatology
关键词 雄激素性秃发 皮肤镜 非那雄胺 米诺地尔 androgenetic alopecia dermoscopy finasteride minoxidil
  • 相关文献

参考文献11

  • 1Inui S. Trichoscopy for common hair loss diseases: Algorithmic method for diagnosis[J]. J Dermatol, 2011, 38(1): 71-75.
  • 2Inui S, Nakajima T, Itami S. Scalp dennoscopy of androgenetic alopecia in Asian people[J]. J Dermatol, 2009, 36(2): 82-85.
  • 3Ross E K, Vincenzi C, Tosti A. Videodermoscopy in the evalua- tion of hair and scalp disorders[J]. J Am Acad Dermatol, 2006, 55(5): 799-806.
  • 4Miteva M, Tosti A. Hair and scalp dermatoscopy[J]. J Am Acad Dermatol, 2012, 67(5): 1040-1048.
  • 5Zhang X, Caulloo S, Zhao Y, et al. Female pattern hair loss: clinico-laboratory findings and trichoscopy depending on disease severity[J]. Int J Trichology, 2012, 4(1): 23-28.
  • 6Blume-Peytavi U, Blumeyer A, Tosti A, et al. S1 guideline for diagnostic evaluation in androgenetic alopecia in men, and adolescents[J]. Br J Dermatol, 2011, 164(1): 5-15.
  • 7Blumeyer A, Tosti A, Messenger A, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopeeia in women and in men[J]. J Dtsch Dermatol Ges, 2011, 9(Suppl 6): S1-S57.
  • 8Tsuboi R, hami S, Inui S, et al. Guidelines for the management of androgenetic alopecia (2010)[J]. J Dermatol, 2012, 39(2): 113- 120.
  • 9慕彰磊,柳小婧,徐峰,盛友渔,齐思思,何欣颐,杨勤萍.非那雄胺与米诺地尔治疗男性雄激素性秃发疗效比较[J].临床皮肤科杂志,2011,40(6):374-376. 被引量:8
  • 10张金燕,仲少敏,杨淑霞,吴艳.影响雄激素源性脱发疗效的相关因素分析[J].中国美容医学,2010,19(8):1176-1179. 被引量:4

二级参考文献15

  • 1陈树新,李洁华,莫玉芳.米诺地尔洗剂与非那雄胺合用治疗雄激素性脱发的临床疗效观察[J].国际医药卫生导报,2006,12(6):64-65. 被引量:10
  • 2杨勤萍,徐峰,孙春秋,周静,盛友渔.非那雄胺及3%复方敏乐啶治疗男性雄激素源性脱发的前瞻性非随机对照临床研究[J].复旦学报(医学版),2006,33(5):695-697. 被引量:3
  • 3Tosti A,Camacho-Martinez F,Dawber R.Management of androgenetic alopecia[J].J Eur Acad Derrnatol Venereol,1999,12:205-214.
  • 4Marc R,Marcelo Gandelman,Russell Knudsen,et al.The potential role ofminoxidil in the hair transplantation setting[J].Dermatol Surg,2002,28:10.
  • 5Antonella Tosti.Bianca Maria Piraccini,Androgenetic alopecia[J].Int J of Dermatol,1999,38:1-7.
  • 6Tosti A,Piraccini BM,Iorizzo M,et al.The natural history of androgenetie alopeeia[J].J Cosmet Dermatol,2005,4:41-43.
  • 7Camacho FM,Garci'a-Hema'ndez MJ,Ferna'ndez-Crehuet JL.Value of hormonal levels in patients with male androgenetie alopecia treated with finasteride:better response in patients under 26 years old[J].Bri J Dermatol,2008,158:1121-1124.
  • 8Van Neste D,Fuh V,Sanchez-Pedreno P,et al.Finasteride increases agen hair in men with androgenetic alopecia[J].Bri J Dermatol,2000,143:804-810.
  • 9Pierre Bouhanna.Androgenetic Alopecia:Combining Medical and Surgical Treatments[J].Dcrmatol Surg,2003,29:1130-1134.
  • 10Ellis JA,Sinclair RD.Male pattern baldness:current treatments,future prospects[J].Drug Discov Today,2008,13(17-18):791-797.

共引文献10

同被引文献99

  • 1陈树新,李洁华,莫玉芳.米诺地尔洗剂与非那雄胺合用治疗雄激素性脱发的临床疗效观察[J].国际医药卫生导报,2006,12(6):64-65. 被引量:10
  • 2Price V.H,Menefee E,SanchezM.,Kaufman K.D,潘敏.男性雄激素依赖性脱发患者应用非那雄胺(1mg/d)治疗后头发重量的变化:3年与4年的疗效[J].世界核心医学期刊文摘(皮肤病学分册),2006,2(9):61-62. 被引量:1
  • 3Harth W, Blume-Peytavi U. Psychotrichology : psychoso-matic aspects of hair diseases [ J ]. J Dtsch DermatolGes,2013,11(2) :125 -135.
  • 4Hadshiew IM, Foitzik K,Arck PC, et al. Burden of hairloss : stress and the underestimated psychosocial impactof telogen effluvium and androgenetic alopecia[ J]. J In-vest Dermatol ,2004,123 (5) :455 -457.
  • 5Branisteanu DE,Voicu CM,Branisteanu DC. Alopecia-a challenge for dermatologists [ J ]. Rev Med Chir SocMed Not 丨asi,2014,118(l) :11 -18.
  • 6Poot F,Antoine E,Gravellier M,et al. A case-control studyon family dysfunction in patients with alopecia areata,psoriasis and atopic dermatitis [ J ]. Acta Derm Venere-ol,2011,91(4) :415 -421.
  • 7Alfani S,Antinone V,Mozzetta A,et al. Psychological sta-tus of patients with alopecia areata [ J ]. Acta Derm Ve-nereol,2012,92( 3) :304-306.
  • 8Rencz F,Gulacsi L,Pentek M,et al. Alopecia areata andhealth-related quality of life: a systematic review andmeta-analysis[ J]. Br J Dermatol,2016,175(2);.
  • 9Kuty-Pachecka M. Psychological and psychopathologicalfactors in alopecia areata [ J ]. Psychiatr Pol,2015,49(10):955 -964.
  • 10Villasonte Fricke AC,Miteva M. Epidemiology and burdenof alopecia areata:a systematic review[ J]. Clin CosmetInvestig Dermatol,2015,8(4) :397 -403.

引证文献9

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部